so management are giving themselves more shares when the share rises to 90 per cent below listings price , is that normal
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025